The global market for Amifampridine was estimated to be worth US$ 837 million in 2023 and is forecast to a readjusted size of US$ 1160.6 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

Amifampridine - Market

Amifampridine (pyridine-3,4-diamine, 3,4-diaminopyridine, 3,4-DAP) is used as a drug, predominantly in the treatment of a number of rare muscle diseases. The free base form of the drug has been used to treat congenital myasthenic syndromes and Lambert–Eaton myasthenic syndrome (LEMS) through compassionate use programs since the 1990s and was recommended as a first line treatment for LEMS in 2006, using ad hoc forms of the drug, since there was no marketed form

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Amifampridine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Amifampridine by region & country, by Type, and by Application.

The Amifampridine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amifampridine.

Market Segmentation

Scope of Amifampridine - Market Report

Report Metric	Details
Report Name	Amifampridine - Market
Forecasted market size in 2030	US$ 1160.6 million
CAGR	4.8%
Forecasted years	2024 - 2030
Segment by Type:	Generic Patent
Segment by Application	Myasthenia Gravis Potassium Channel Blocker
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Jacobus Pharmaceutical, Unichem, BioMarin Pharmaceutical, Wockhardt, Glenmark Pharmaceuticals, Norris Pharm, BLD Pharm, Biosynth AG, Innovapharm, Founder Pharma, BroadPharm, CSNpharm, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Amifampridine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Amifampridine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Amifampridine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Amifampridine - Market size in 2030?

Ans: The Amifampridine - Market size in 2030 will be US$ 1160.6 million.

Who are the main players in the Amifampridine - Market report?

Ans: The main players in the Amifampridine - Market are Jacobus Pharmaceutical, Unichem, BioMarin Pharmaceutical, Wockhardt, Glenmark Pharmaceuticals, Norris Pharm, BLD Pharm, Biosynth AG, Innovapharm, Founder Pharma, BroadPharm, CSNpharm, Merck

What are the Application segmentation covered in the Amifampridine - Market report?

Ans: The Applications covered in the Amifampridine - Market report are Myasthenia Gravis, Potassium Channel Blocker

What are the Type segmentation covered in the Amifampridine - Market report?

Ans: The Types covered in the Amifampridine - Market report are Generic, Patent

1 Market Overview

1.1 Amifampridine Product Introduction

1.2 Global Amifampridine Market Size Forecast

1.2.1 Global Amifampridine Sales Value (2019-2030)

1.2.2 Global Amifampridine Sales Volume (2019-2030)

1.2.3 Global Amifampridine Sales Price (2019-2030)

1.3 Amifampridine Market Trends & Drivers

1.3.1 Amifampridine Industry Trends

1.3.2 Amifampridine Market Drivers & Opportunity

1.3.3 Amifampridine Market Challenges

1.3.4 Amifampridine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Amifampridine Players Revenue Ranking (2023)

2.2 Global Amifampridine Revenue by Company (2019-2024)

2.3 Global Amifampridine Players Sales Volume Ranking (2023)

2.4 Global Amifampridine Sales Volume by Company Players (2019-2024)

2.5 Global Amifampridine Average Price by Company (2019-2024)

2.6 Key Manufacturers Amifampridine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Amifampridine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Amifampridine

2.9 Amifampridine Market Competitive Analysis

2.9.1 Amifampridine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Amifampridine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifampridine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Generic

3.1.2 Patent

3.2 Global Amifampridine Sales Value by Type

3.2.1 Global Amifampridine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Amifampridine Sales Value, by Type (2019-2030)

3.2.3 Global Amifampridine Sales Value, by Type (%) (2019-2030)

3.3 Global Amifampridine Sales Volume by Type

3.3.1 Global Amifampridine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Amifampridine Sales Volume, by Type (2019-2030)

3.3.3 Global Amifampridine Sales Volume, by Type (%) (2019-2030)

3.4 Global Amifampridine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Myasthenia Gravis

4.1.2 Potassium Channel Blocker

4.2 Global Amifampridine Sales Value by Application

4.2.1 Global Amifampridine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Amifampridine Sales Value, by Application (2019-2030)

4.2.3 Global Amifampridine Sales Value, by Application (%) (2019-2030)

4.3 Global Amifampridine Sales Volume by Application

4.3.1 Global Amifampridine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Amifampridine Sales Volume, by Application (2019-2030)

4.3.3 Global Amifampridine Sales Volume, by Application (%) (2019-2030)

4.4 Global Amifampridine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Amifampridine Sales Value by Region

5.1.1 Global Amifampridine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Amifampridine Sales Value by Region (2019-2024)

5.1.3 Global Amifampridine Sales Value by Region (2025-2030)

5.1.4 Global Amifampridine Sales Value by Region (%), (2019-2030)

5.2 Global Amifampridine Sales Volume by Region

5.2.1 Global Amifampridine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Amifampridine Sales Volume by Region (2019-2024)

5.2.3 Global Amifampridine Sales Volume by Region (2025-2030)

5.2.4 Global Amifampridine Sales Volume by Region (%), (2019-2030)

5.3 Global Amifampridine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Amifampridine Sales Value, 2019-2030

5.4.2 North America Amifampridine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Amifampridine Sales Value, 2019-2030

5.5.2 Europe Amifampridine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Amifampridine Sales Value, 2019-2030

5.6.2 Asia Pacific Amifampridine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Amifampridine Sales Value, 2019-2030

5.7.2 South America Amifampridine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Amifampridine Sales Value, 2019-2030

5.8.2 Middle East & Africa Amifampridine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Amifampridine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Amifampridine Sales Value

6.2.1 Key Countries/Regions Amifampridine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Amifampridine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Amifampridine Sales Value, 2019-2030

6.3.2 United States Amifampridine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Amifampridine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Amifampridine Sales Value, 2019-2030

6.4.2 Europe Amifampridine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Amifampridine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Amifampridine Sales Value, 2019-2030

6.5.2 China Amifampridine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Amifampridine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Amifampridine Sales Value, 2019-2030

6.6.2 Japan Amifampridine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Amifampridine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Amifampridine Sales Value, 2019-2030

6.7.2 South Korea Amifampridine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Amifampridine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Amifampridine Sales Value, 2019-2030

6.8.2 Southeast Asia Amifampridine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Amifampridine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Amifampridine Sales Value, 2019-2030

6.9.2 India Amifampridine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Amifampridine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Jacobus Pharmaceutical

7.1.1 Jacobus Pharmaceutical Company Information

7.1.2 Jacobus Pharmaceutical Introduction and Business Overview

7.1.3 Jacobus Pharmaceutical Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Jacobus Pharmaceutical Amifampridine Product Offerings

7.1.5 Jacobus Pharmaceutical Recent Development

7.2 Unichem

7.2.1 Unichem Company Information

7.2.2 Unichem Introduction and Business Overview

7.2.3 Unichem Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Unichem Amifampridine Product Offerings

7.2.5 Unichem Recent Development

7.3 BioMarin Pharmaceutical

7.3.1 BioMarin Pharmaceutical Company Information

7.3.2 BioMarin Pharmaceutical Introduction and Business Overview

7.3.3 BioMarin Pharmaceutical Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 BioMarin Pharmaceutical Amifampridine Product Offerings

7.3.5 BioMarin Pharmaceutical Recent Development

7.4 Wockhardt

7.4.1 Wockhardt Company Information

7.4.2 Wockhardt Introduction and Business Overview

7.4.3 Wockhardt Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Wockhardt Amifampridine Product Offerings

7.4.5 Wockhardt Recent Development

7.5 Glenmark Pharmaceuticals

7.5.1 Glenmark Pharmaceuticals Company Information

7.5.2 Glenmark Pharmaceuticals Introduction and Business Overview

7.5.3 Glenmark Pharmaceuticals Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Glenmark Pharmaceuticals Amifampridine Product Offerings

7.5.5 Glenmark Pharmaceuticals Recent Development

7.6 Norris Pharm

7.6.1 Norris Pharm Company Information

7.6.2 Norris Pharm Introduction and Business Overview

7.6.3 Norris Pharm Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Norris Pharm Amifampridine Product Offerings

7.6.5 Norris Pharm Recent Development

7.7 BLD Pharm

7.7.1 BLD Pharm Company Information

7.7.2 BLD Pharm Introduction and Business Overview

7.7.3 BLD Pharm Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 BLD Pharm Amifampridine Product Offerings

7.7.5 BLD Pharm Recent Development

7.8 Biosynth AG

7.8.1 Biosynth AG Company Information

7.8.2 Biosynth AG Introduction and Business Overview

7.8.3 Biosynth AG Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Biosynth AG Amifampridine Product Offerings

7.8.5 Biosynth AG Recent Development

7.9 Innovapharm

7.9.1 Innovapharm Company Information

7.9.2 Innovapharm Introduction and Business Overview

7.9.3 Innovapharm Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Innovapharm Amifampridine Product Offerings

7.9.5 Innovapharm Recent Development

7.10 Founder Pharma

7.10.1 Founder Pharma Company Information

7.10.2 Founder Pharma Introduction and Business Overview

7.10.3 Founder Pharma Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Founder Pharma Amifampridine Product Offerings

7.10.5 Founder Pharma Recent Development

7.11 BroadPharm

7.11.1 BroadPharm Company Information

7.11.2 BroadPharm Introduction and Business Overview

7.11.3 BroadPharm Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 BroadPharm Amifampridine Product Offerings

7.11.5 BroadPharm Recent Development

7.12 CSNpharm

7.12.1 CSNpharm Company Information

7.12.2 CSNpharm Introduction and Business Overview

7.12.3 CSNpharm Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 CSNpharm Amifampridine Product Offerings

7.12.5 CSNpharm Recent Development

7.13 Merck

7.13.1 Merck Company Information

7.13.2 Merck Introduction and Business Overview

7.13.3 Merck Amifampridine Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Merck Amifampridine Product Offerings

7.13.5 Merck Recent Development

8 Industry Chain Analysis

8.1 Amifampridine Industrial Chain

8.2 Amifampridine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Amifampridine Sales Model

8.5.2 Sales Channel

8.5.3 Amifampridine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Jacobus Pharmaceutical

Unichem

BioMarin Pharmaceutical

WOCKHARDT

Glenmark Pharmaceuticals

List of Tables

Table 1. Amifampridine Market Trends

Table 2. Amifampridine Market Drivers & Opportunity

Table 3. Amifampridine Market Challenges

Table 4. Amifampridine Market Restraints

Table 5. Global Amifampridine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Amifampridine Revenue Market Share by Company (2019-2024)

Table 7. Global Amifampridine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Amifampridine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Amifampridine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Amifampridine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Amifampridine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Amifampridine

Table 13. Global Amifampridine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifampridine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Amifampridine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Amifampridine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Amifampridine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Amifampridine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Amifampridine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Amifampridine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Amifampridine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Amifampridine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Amifampridine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Amifampridine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Amifampridine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Amifampridine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Amifampridine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Amifampridine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Amifampridine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Amifampridine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Amifampridine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Amifampridine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Amifampridine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Amifampridine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Amifampridine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Amifampridine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Amifampridine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Amifampridine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Amifampridine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Amifampridine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Amifampridine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Amifampridine Sales Value by Region (2019-2024) & (%)

Table 44. Global Amifampridine Sales Value by Region (2025-2030) & (%)

Table 45. Global Amifampridine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Amifampridine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Amifampridine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Amifampridine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Amifampridine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Amifampridine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Amifampridine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Amifampridine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Amifampridine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Amifampridine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Amifampridine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Amifampridine Sales Volume, (2025-2030) & (K Units)

Table 57. Jacobus Pharmaceutical Company Information

Table 58. Jacobus Pharmaceutical Introduction and Business Overview

Table 59. Jacobus Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Jacobus Pharmaceutical Amifampridine Product Offerings

Table 61. Jacobus Pharmaceutical Recent Development

Table 62. Unichem Company Information

Table 63. Unichem Introduction and Business Overview

Table 64. Unichem Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Unichem Amifampridine Product Offerings

Table 66. Unichem Recent Development

Table 67. BioMarin Pharmaceutical Company Information

Table 68. BioMarin Pharmaceutical Introduction and Business Overview

Table 69. BioMarin Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. BioMarin Pharmaceutical Amifampridine Product Offerings

Table 71. BioMarin Pharmaceutical Recent Development

Table 72. Wockhardt Company Information

Table 73. Wockhardt Introduction and Business Overview

Table 74. Wockhardt Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Wockhardt Amifampridine Product Offerings

Table 76. Wockhardt Recent Development

Table 77. Glenmark Pharmaceuticals Company Information

Table 78. Glenmark Pharmaceuticals Introduction and Business Overview

Table 79. Glenmark Pharmaceuticals Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Glenmark Pharmaceuticals Amifampridine Product Offerings

Table 81. Glenmark Pharmaceuticals Recent Development

Table 82. Norris Pharm Company Information

Table 83. Norris Pharm Introduction and Business Overview

Table 84. Norris Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Norris Pharm Amifampridine Product Offerings

Table 86. Norris Pharm Recent Development

Table 87. BLD Pharm Company Information

Table 88. BLD Pharm Introduction and Business Overview

Table 89. BLD Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. BLD Pharm Amifampridine Product Offerings

Table 91. BLD Pharm Recent Development

Table 92. Biosynth AG Company Information

Table 93. Biosynth AG Introduction and Business Overview

Table 94. Biosynth AG Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Biosynth AG Amifampridine Product Offerings

Table 96. Biosynth AG Recent Development

Table 97. Innovapharm Company Information

Table 98. Innovapharm Introduction and Business Overview

Table 99. Innovapharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Innovapharm Amifampridine Product Offerings

Table 101. Innovapharm Recent Development

Table 102. Founder Pharma Company Information

Table 103. Founder Pharma Introduction and Business Overview

Table 104. Founder Pharma Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Founder Pharma Amifampridine Product Offerings

Table 106. Founder Pharma Recent Development

Table 107. BroadPharm Company Information

Table 108. BroadPharm Introduction and Business Overview

Table 109. BroadPharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. BroadPharm Amifampridine Product Offerings

Table 111. BroadPharm Recent Development

Table 112. CSNpharm Company Information

Table 113. CSNpharm Introduction and Business Overview

Table 114. CSNpharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. CSNpharm Amifampridine Product Offerings

Table 116. CSNpharm Recent Development

Table 117. Merck Company Information

Table 118. Merck Introduction and Business Overview

Table 119. Merck Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Merck Amifampridine Product Offerings

Table 121. Merck Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Amifampridine Downstream Customers

Table 125. Amifampridine Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Amifampridine Product Picture

Figure 2. Global Amifampridine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Amifampridine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Amifampridine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Amifampridine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Amifampridine Report Years Considered

Figure 7. Global Amifampridine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Amifampridine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Amifampridine Revenue in 2023

Figure 10. Amifampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Generic Picture

Figure 12. Patent Picture

Figure 13. Global Amifampridine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Amifampridine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Amifampridine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Amifampridine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Amifampridine Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Myasthenia Gravis

Figure 19. Product Picture of Potassium Channel Blocker

Figure 20. Global Amifampridine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Amifampridine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Amifampridine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Amifampridine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Amifampridine Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Amifampridine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Amifampridine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Amifampridine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Amifampridine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Amifampridine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Amifampridine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Amifampridine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Amifampridine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Amifampridine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Amifampridine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Amifampridine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Amifampridine Sales Volume (%), (2019-2030)

Figure 37. United States Amifampridine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Amifampridine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Amifampridine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Amifampridine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Amifampridine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Amifampridine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Amifampridine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Amifampridine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Amifampridine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Amifampridine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Amifampridine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Amifampridine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Amifampridine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Amifampridine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Amifampridine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Amifampridine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Amifampridine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Amifampridine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Amifampridine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Amifampridine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Amifampridine Sales Value by Application (%), 2023 VS 2030

Figure 58. Amifampridine Industrial Chain

Figure 59. Amifampridine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Autism Intervention Software Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37O18689

Wed Dec 11 00:00:00 UTC 2024

Add to Cart

D-Amphetamine Sulfate API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-0I12614

Fri Dec 06 00:00:00 UTC 2024

Add to Cart

Relapsing-Remitting Multiple Sclerosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-19Z9868

Wed Dec 04 00:00:00 UTC 2024

Add to Cart

ADHD Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-27T10171

Tue Dec 03 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions